Cleared Traditional

K920828 - SAFE-PICC PERIPHERALLY INSERTED CENTRAL...

K920828 is the FDA 510(k) clearance for SAFE-PICC PERIPHERALLY INSERTED CENTRAL... by Menlo Care, Inc.. It is a Class 2 General Hospital device (product code FOZ) cleared through the Traditional 510(k) pathway after a 172-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1992
Decision
172d
Days
Class 2
Risk

K920828 is an FDA 510(k) clearance for the SAFE-PICC PERIPHERALLY INSERTED CENTRAL VENOUS CAT. Classified as Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days (product code FOZ), Class II - Special Controls.

Submitted by Menlo Care, Inc. (Menlo Park, US). The FDA issued a Cleared decision on August 14, 1992 after a review of 172 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5200 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Menlo Care, Inc. devices

Submission Details

510(k) Number K920828 FDA.gov
FDA Decision Cleared Substantially Equivalent - De Novo Granted (SEKD)
Date Received February 24, 1992
Decision Date August 14, 1992
Days to Decision 172 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
43d slower than avg
Panel avg: 129d · This submission: 172d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FOZ Catheter, Intravascular, Therapeutic, Short-term Less Than 30 Days

All 265
Devices cleared under the same product code (FOZ) and FDA review panel - the closest regulatory comparables to K920828.
PHARMACIA DELTEC PERIPHERALLY INSERTED VENOUS CATH
K926544 · Pharmacia Deltec, Inc. · Mar 1994
CHANGES TO PROTECTIV(TM) & JELCO(TM) WINGED CATH
K933050 · Critikon Company, LLC · Dec 1993
SAFE-DWELL PLUS CENTRAL VENOUS CATHETER
K921270 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Sep 1992
E-Z SET/MINICATH INFUSION SETS
K920635 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1992
LANDMARK MIDLINE CATHETER
K920028 · Menlo Care, Inc. · Mar 1992
VERSACATH MAINLINE CENTRAL VENOUS CATHETER
K920128 · Menlo Care, Inc. · Mar 1992